NYSE · Medical - Distribution

McKesson Corporation (MCK) Stock

$930.25 +2.19% NYSE: MCK Healthcare

Valuation

MetricValue
Price$930.25
Market Cap$108.91B
P/E Ratio24.26
P/B Ratio-25.48
P/S Ratio0.26
EPS (TTM)$38.38
52-Week High$999.00
52-Week Low$723.68
Dividend Yield0.41%

Financials & Margins

MetricValue
ROE-194.39%
ROA5.20%
ROCE37.02%
Gross Margin1.54%
Operating Margin1.54%
Net Margin1.12%
Debt/Equity-2.76
Current Ratio0.85

Annual Financials (USD)

Metric20222023202420252026
Revenue$264.0B$276.7B$309.0B$359.1B$403.4B
Operating Profit$2.7B$4.5B$3.9B$4.4B$6.5B
Net Profit$1.1B$3.6B$3.0B$3.3B$4.8B
EPS$7.23$25.04$22.39$25.72$38.38
Op Margin1.0%1.6%1.3%1.2%1.6%

Balance Sheet (USD)

Metric20222023202420252026
Total Assets$63.3B$62.3B$67.4B$75.1B$82.3B
Total Liabilities$65.1B$63.8B$69.0B$76.8B$83.2B
Cash$3.5B$4.7B$4.6B$5.7B$4.0B
Borrowings$7.5B$7.3B$7.4B$7.4B$8.6B

Latest News

2 Profitable Stocks Worth Investigating and 1 We Turn Down StockStory · Jul 15, 2026 McKesson (MCK) Stock Dips While Market Gains: Key Facts Zacks · Jul 14, 2026 Cheniere Appoints Britt Vitalone to Board of Directors Business Wire · Jul 14, 2026 Leerink Partners Adjusts Price Target on McKesson to $950 From $970, Maintains Outperform Rating MT Newswires · Jul 14, 2026 Zacks Industry Outlook McKesson, Cardinal, West Pharmaceutical, Align and Henry Zacks · Jul 14, 2026

Cash Flow (USD)

Metric20222023202420252026
Operating Cash Flow$4.4B$5.2B$4.3B$6.1B$6.2B
Investing Cash Flow$-624.0M$-1.1B$-1.8B$-1.6B$-4.2B
Financing Cash Flow$-4.9B$-4.0B$-3.2B$-3.7B$-5.1B
Net Cash Flow$-2.5B$744.0M$-94.0M$1.4B$-2.0B
Free Cash Flow$3.9B$4.6B$3.6B$5.2B$5.4B

Valuation & Return Ratios

MetricValue
PEG Ratio0.50
EV / EBITDA15.83
FCF Yield5.80%
Quick Ratio0.52
Interest Coverage43.49
Return 1Y24.82%
Return 3Y109.75%
Return 5Y373.82%

Ownership

Insiders Held0.05%
Institutions Held95.69%
Institutions Float Held95.74%
Institutional HolderSharesReport Date
Blackrock Inc.11,418,3842026-03-31
Vanguard Capital Management LLC7,960,7242026-03-31
State Street Corporation5,731,7562026-03-31
FMR, LLC3,603,4232026-03-31
JPMORGAN CHASE & CO3,268,3402026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACHAccendra Health, Inc. $0.44 -6.28% -0.12 $33.94M 0.00%
CAHCardinal Health, Inc. $238.96 +2.93% 31.93 $55.97B 0.89%
CORCencora, Inc. $321.35 +1.29% 22.21 $62.52B 0.80%
SHPMYShanghai Pharmaceuticals Holding Co., Ltd $7.34 +0.00% 10.56 $5.44B 6.95%
SHTDYSinopharm Group Co. Ltd. $10.83 -1.81% 6.40 $6.76B 4.71%

About McKesson Corporation

McKesson Corporation is led by CEO Brian S. Tyler, employs 44,000 people, headquartered in Irving, US, publicly traded since 1994.

McKesson Corporation (MCK) stock trades at $930.25 with a market capitalization of $108.91B. The stock is valued at a price-to-earnings (P/E) ratio of 24.26, price-to-book of -25.48, price-to-sales of 0.26. Over the past 52 weeks the stock has ranged between $723.68 and $999.00, and currently trades 6.9% below its 52-week high. It pays a dividend yielding 0.41%.

On profitability, McKesson Corporation generates a return on equity (ROE) of -194.39%, return on capital employed of 37.02%, an operating margin of 1.54%, a net profit margin of 1.12%.

In its most recent fiscal year, McKesson Corporation reported annual revenue of $403.4B, net profit of $4.8B, revenue has compounded at 11.1% a year over the last five years.

The balance sheet shows a debt-to-equity ratio of -2.76 — a conservative balance sheet with little leverage risk, a current ratio of 0.85, total assets of $82.3B, $4.0B in cash and equivalents.

MCK has a beta of 0.30 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1169.93 -1.58% JNJ Johnson & Johnson $256.48 -0.76% ABBV AbbVie Inc. $272.42 +0.39% MRK Merck & Company, Inc. Common Stock (new) $142.40 -0.28% UNH UnitedHealth Group Incorporated Common Stock (DE) $370.95 -1.34% NVS Novartis AG $143.11 -0.12% AZN AstraZeneca PLC $158.78 -0.84% TMO Thermo Fisher Scientific Inc $651.98 -1.52% AMGN Amgen Inc. $407.44 -1.37% GILD Gilead Sciences, Inc. $147.10 +0.17% ABT Abbott Laboratories $98.49 -0.24% NVO Novo Nordisk A/S $38.18 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides